Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells
Sunandan Saha, Lauren E Woodard, Elizabeth M Charron, Richard C Welch, Cliona M Rooney, Matthew H Wilson, Sunandan Saha, Lauren E Woodard, Elizabeth M Charron, Richard C Welch, Cliona M Rooney, Matthew H Wilson
Abstract
Non-viral transposons have been used successfully for genetic modification of clinically relevant cells including embryonic stem, induced pluripotent stem, hematopoietic stem and primary human T cell types. However, there has been limited evaluation of undesired genomic effects when using transposons for human genome modification. The prevalence of piggyBac(PB)-like terminal repeat (TR) elements in the human genome raises concerns. We evaluated if there were undesired genomic effects of the PB transposon system to modify human cells. Expression of the transposase alone revealed no mobilization of endogenous PB-like sequences in the human genome and no increase in DNA double-strand breaks. The use of PB in a plasmid containing both transposase and transposon greatly increased the probability of transposase integration; however, using transposon and transposase from separate vectors circumvented this. Placing a eGFP transgene within transposon vector backbone allowed isolation of cells free from vector backbone DNA. We confirmed observable directional promoter activity within the 5'TR element of PB but found no significant enhancer effects from the transposon DNA sequence. Long-term culture of primary human cells modified with eGFP-transposons revealed no selective growth advantage of transposon-harboring cells. PB represents a promising vector system for genetic modification of human cells with limited undesired genomic effects.
Published by Oxford University Press on behalf of Nucleic Acids Research 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Figures
References
- Vandendriessche T., Ivics Z., Izsvak Z., Chuah M.K. Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood. 2009;114:1461–1468.
- Ivics Z., Hackett P.B., Plasterk R.H., Izsvak Z. Molecular reconstruction of Sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell. 1997;91:501–510.
- Wilson M.H., Coates C.J., George A.L., Jr PiggyBac transposon-mediated gene transfer in human cells. Mol. Ther. 2007;15:139–145.
- Hackett P.B., Largaespada D.A., Cooper L.J. A transposon and transposase system for human application. Mol. Ther. 2010;18:674–683.
- Li M.A., Turner D.J., Ning Z., Yusa K., Liang Q., Eckert S., Rad L., Fitzgerald T.W., Craig N.L., Bradley A. Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res. 2011;39:e148.
- Li M.A., Pettitt S.J., Eckert S., Ning Z., Rice S., Cadinanos J., Yusa K., Conte N., Bradley A. The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sites. Mol. Cell Biol. 2013;33:1317–1330.
- Doherty J.E., Huye L.E., Yusa K., Zhou L., Craig N.L., Wilson M.H. Hyperactive piggyBac gene transfer in human cells and in vivo. Hum. Gene Ther. 2012;23:311–320.
- Owens J.B., Urschitz J., Stoytchev I., Dang N.C., Stoytcheva Z., Belcaid M., Maragathavally K.J., Coates C.J., Segal D.J., Moisyadi S. Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res. 2012;40:6978–6991.
- Owens J.B., Mauro D., Stoytchev I., Bhakta M.S., Kim M.S., Segal D.J., Moisyadi S. Transcription activator like effector (TALE)-directed piggyBac transposition in human cells. Nucleic Acids Res. 2013;41:9197–9207.
- Kettlun C., Galvan D.L., George A.L., Jr, Kaja A., Wilson M.H. Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol. Ther. 2011;19:1636–1644.
- Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 2009;458:771–775.
- Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009;458:766–770.
- Yusa K., Rad R., Takeda J., Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods. 2009;6:363–369.
- Nakazawa Y., Huye L.E., Dotti G., Foster A.E., Vera J.F., Manuri P.R., June C.H., Rooney C.M., Wilson M.H. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J. Immunother. 2009;32:826–836.
- Nakazawa Y., Huye L.E., Salsman V.S., Leen A.M., Ahmed N., Rollins L., Dotti G., Gottschalk S.M., Wilson M.H., Rooney C.M. PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol. Ther. 2011;19:2133–2143.
- Manuri P.V., Wilson M.H., Maiti S.N., Mi T., Singh H., Olivares S., Dawson M.J., Huls H., Lee D.A., Rao P.H., et al. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum. Gene Ther. 2010;21:427–437.
- Feschotte C. The piggyBac transposon holds promise for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 2006;103:14981–14982.
- Singh H., Huls H., Kebriaei P., Cooper L.J. A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19. Immunol. Rev. 2014;257:181–190.
- Kahlig K.M., Saridey S.K., Kaja A., Daniels M.A., George A.L., Jr, Wilson M.H. Multiplexed transposon-mediated stable gene transfer in human cells. Proc. Natl. Acad. Sci. U.S.A. 2010;107:1343–1348.
- Shechter D., Dormann H.L., Allis C.D., Hake S.B. Extraction, purification and analysis of histones. Nat. Protoc. 2007;2:1445–1457.
- Saridey S.K., Liu L., Doherty J.E., Kaja A., Galvan D.L., Fletcher B.S., Wilson M.H. PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol. Ther. 2009;17:2115–2120.
- Woodard L.E., Li X., Malani N., Kaja A., Hice R.H., Atkinson P.W., Bushman F.D., Craig N.L., Wilson M.H. Comparative analysis of the recently discovered hAT transposon TcBuster in human cells. PLoS. One. 2012;7:e42666.
- Bi Y., Liu X., Zhang L., Shao C., Ma Z., Hua Z., Zhang L., Li L., Hua W., Xiao H., et al. Pseudo attP sites in favor of transgene integration and expression in cultured porcine cells identified by Streptomyces phage phiC31 integrase. BMC. Mol. Biol. 2013;14:20.
- Hayasaka N., LaRue S.I., Green C.B. Differential contribution of rod and cone circadian clocks in driving retinal melatonin rhythms in Xenopus. PLoS. One. 2010;5:e15599.
- Huye L.E., Nakazawa Y., Patel M.P., Yvon E., Sun J., Savoldo B., Wilson M.H., Dotti G., Rooney C.M. Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Mol. Ther. 2011;19:2239–2248.
- Tanaka T., Kurose A., Huang X., Dai W., Darzynkiewicz Z. ATM activation and histone H2AX phosphorylation as indicators of DNA damage by DNA topoisomerase I inhibitor topotecan and during apoptosis. Cell Prolif. 2006;39:49–60.
- Fraser M.J., Ciszczon T., Elick T., Bauser C. Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol. Biol. 1996;5:141–151.
- Li X., Lobo N., Bauser C.A., Fraser M.J., Jr The minimum internal and external sequence requirements for transposition of the eukaryotic transformation vector piggyBac. Mol. Genet. Genomics. 2001;266:190–198.
- Cary L.C., Goebel M., Corsaro B.G., Wang H.G., Rosen E., Fraser M.J. Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology. 1989;172:156–169.
- Yusa K., Zhou L., Li M.A., Bradley A., Craig N.L. A hyperactive piggyBac transposase for mammalian applications. Proc. Natl. Acad. Sci. U.S.A. 2011;108:1531–1536.
- Bauser C.A., Elick T.A., Fraser M.J. Proteins from nuclear extracts of two lepidopteran cell lines recognize the ends of TTAA-specific transposons piggyBac and tagalong. Insect Mol. Biol. 1999;8:223–230.
- Liu G.Y., Aronovich E.L., Cui Z.B., Whitley C.B., Hackett P.B. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J. Gene Med. 2004;6:574–583.
- Solodushko V., Bitko V., Fouty B. Minimal piggyBac vectors for chromatin integration. Gene Ther. 2014;21:1–9.
- Urschitz J., Kawasumi M., Owens J., Morozumi K., Yamashiro H., Stoytchev I., Marh J., Dee J.A., Kawamoto K., Coates C.J., et al. Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects. Proc. Natl. Acad. Sci. U.S.A. 2010;107:8117–8122.
- Cadinanos J., Bradley A. Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res. 2007;35:e87.
- Wang W., Lin C., Lu D., Ning Z., Cox T., Melvin D., Wang X., Bradley A., Liu P. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2008;105:9290–9295.
- Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352.
- Cai Y., Bak R.O., Krogh L.B., Staunstrup N.H., Moldt B., Corydon T.J., Schroder L.D., Mikkelsen J.G. DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors. Nucleic Acids Res. 2013;42:e28.
- Wilber A., Frandsen J.L., Geurts J.L., Largaespada D.A., Hackett P.B., Mcivor R.S. RNA as a source of transposase for sleeping beauty-mediated gene insertion and expression in somatic cells and tissues. Mol. Ther. 2006;13:625–630.
- Nakazawa Y., Saha S., Galvan D.L., Huye L., Rollins L., Rooney C.M., Wilson M.H. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. J. Immunother. 2013;36:3–10.
- Shi X., Harrison R.L., Hollister J.R., Mohammed A., Fraser M.J., Jr, Jarvis D.L. Construction and characterization of new piggyBac vectors for constitutive or inducible expression of heterologous gene pairs and the identification of a previously unrecognized activator sequence in piggyBac. BMC Biotechnol. 2007;7:5.
- Sharma N., Hollensen A.K., Bak R.O., Staunstrup N.H., Schroder L.D., Mikkelsen J.G. The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells. PLoS One. 2012;7:e48421.
- Li X., Ewis H., Hice R.H., Malani N., Parker N., Zhou L., Feschotte C., Bushman F.D., Atkinson P.W., Craig N.L. A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture. Proc. Natl. Acad. Sci. U.S.A. 2013;110:E478–E487.
Source: PubMed